APA citáció

Gönczi Lóránt, Kürti Zsuzsanna, Rutka Mariann, Végh Zsuzsanna, Farkas Klaudia, Lovász Barbara Dorottya, . . . Lakatos Péter László. (2017). Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.

Chicago Style (17th ed.) Citation

Gönczi Lóránt, et al. Drug Persistence and Need for Dose Intensification to Adalimumab Therapy; the Importance of Therapeutic Drug Monitoring in Inflammatory Bowel Diseases. Biomed Central Ltd, 2017.

MLA idézés

Gönczi Lóránt, et al. Drug Persistence and Need for Dose Intensification to Adalimumab Therapy; the Importance of Therapeutic Drug Monitoring in Inflammatory Bowel Diseases. 2017.